We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000596:SZSEAnhui Gujing Distillery Co., Ltd. Analysis

Data as of 2026-03-17 - not real-time

CN¥114.53

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at CNY 114.53, well below its 20‑day (≈119), 50‑day (≈128) and 200‑day (≈146) moving averages, signaling a bearish technical backdrop. However, the MACD histogram has turned positive and the RSI sits near 38, suggesting the price may be approaching oversold conditions and could test the nearby support at CNY 110.1. Volatility remains high at roughly 45% over the past month, while the beta of 0.1 indicates the share moves largely independent of broader market swings. On the fundamentals side, revenue has slumped by more than 50%, yet the company maintains robust gross (≈80%) and profit margins (≈23%) and generates a healthy cash pile of CNY 14.5 bn against modest debt. The dividend yield of 5.25% with a payout ratio around 67% provides attractive income, but free cash flow is currently negative, raising a modest sustainability question. A discounted cash flow model places fair value near CNY 62, implying the market price is significantly above intrinsic estimates, while analysts’ consensus targets in the high‑170s reflect optimism about a turnaround. Balancing the technical bounce potential, strong cash balance, and high yield against the steep revenue decline and valuation gap suggests a cautious but opportunistic stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near strong support level
  • Bullish MACD histogram hinting at a short‑term bounce
  • High dividend yield offering downside protection

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst consensus targets well above current price
  • Strong cash reserves and low leverage
  • Potential recovery in revenue after recent contraction

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustained high dividend yield supporting total return
  • Persistent revenue decline and negative free cash flow
  • Valuation gap between market price and DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth-51.60%
Profit Margin22.60%
P/E Ratio12.8
ROE19.02%
ROA9.81%
Debt/Equity1.78
P/B Ratio2.4
Op. Cash FlowCN¥2.0B
Free Cash FlowCN¥-1313803904

Technical Analysis

TrendBearish
RSI38.3
SupportCN¥110.11
ResistanceCN¥133.28
MA 20CN¥119.15
MA 50CN¥128.18
MA 200CN¥145.83
MACDBullish
VolumeDecreasing
Fear & Greed Index79.45

Valuation

Fair ValueCN¥62.56
Target PriceCN¥172.32
Upside/Downside50.46%
GradeOvervalued
TypeValue
Dividend Yield5.25%

Risk Assessment

Beta0.10
Volatility44.98%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.